Predilife (XPAR:ALPRE) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 08, 2026)


XPAR:ALPRE Predilife SA XPAR:ALPRE
32 GF Score
Price €2.10
GF Value €18.98
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Predilife Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Predilife's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

XPAR:ALPRE vs TMO, DHR, IDXX: Margin of Safety % (DCF Earnings Based) Comparison

For the Diagnostics & Research subindustry, Predilife's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Predilife Margin of Safety % (DCF Earnings Based) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Predilife's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Predilife's Margin of Safety % (DCF Earnings Based) falls into.


XPAR:ALPRE
32GF Score
Predilife SA XPAR:ALPRE
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Predilife (XPAR:ALPRE) Overvalued in 2026?

Based on GuruFocus' analysis, Predilife stock appears to be undervalued. The current stock price of €2.10 is trading 88.9% below its estimated GF Value™ of €18.98. GuruFocus considers Predilife to be Possible Value Trap.

Key valuation signals for XPAR:ALPRE:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €18.98 vs. price of €2.10 (88.9% below fair value)
  • GF Score™: 32/100 with 5 warning signs

No single metric tells the full story. See the XPAR:ALPRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Predilife Business Description

Other Exchanges 0GA:Germany
Address 39 rue Camille Desmoulins, Villejuif, Villejuif, FRA, 94805
Predilife SA develops solutions for predictive medicine, combining medical techniques (genetic tests, medical imaging) and mathematical models with a large amount of statistical data, which allows each individual to define their risk profile for the occurrence of various serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.
32GF Score

Get the complete analysis for XPAR:ALPRE

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.10
Price
€18.98
GF Value